Once reconstituted with bacteriostatic water, stability drops dramatically: even under ideal refrigeration (28C), the peptide loses 58% potency weekly through oxidative methionine degradation
Food and Drug Administration (FDA) for chronic weight management
Do not view weight regain as a personal failure
However, Sermorelin excels in promoting long-term metabolic improvements, which may lead to sustainable benefits over time
Supporting data for tirzepatide come from two RCTs, including SURMOUNT-1
To receive a prescription of either medication through the NHS you must: have a BMI of 40 or more (or 37.5 and above for certain ethnic groups) have at least at least four weight-related health conditions, such as type 2 diabetes, high blood pressure, heart disease, or sleep apnoea have the medication prescribed through a specialist weight management service Differences Licencing Mounjaro is licenced and approved in the UK for loss treatment